Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
Holding CRVS?
Track your performance easily

Corvus Pharmaceuticals (CRVS) Financial Statements

533 Followers

Corvus Pharmaceuticals Financial Overview

Corvus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.445; its P/E ratio is -21.20; Corvus Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.26M$ -6.25M$ -5.65M$ -5.56M$ -6.50M
EBITDA$ -4.09M$ -6.23M$ -5.62M$ -5.53M$ -6.20M
Net Income Common Stockholders$ -4.26M$ -5.70M$ -6.65M$ -6.00M$ -12.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 47.25M$ 22.13M$ 27.15M$ 32.17M$ 37.02M
Total Assets$ 64.56M$ 40.08M$ 45.55M$ 51.94M$ 58.04M
Total Debt$ 700.00K$ 1.04M$ 1.37M$ 1.69M$ 2.00M
Net Debt$ -46.55M$ -21.09M$ -25.77M$ -30.48M$ -35.02M
Total Liabilities$ 6.22M$ 6.72M$ 6.87M$ 7.65M$ 8.56M
Stockholders Equity$ 58.31M$ 33.38M$ 38.68M$ 44.29M$ 49.48M
Cash Flow-
Free Cash Flow$ -5.48M$ -5.16M$ -5.17M$ -5.43M$ -5.22M
Operating Cash Flow$ -5.48M$ -5.16M$ -5.17M$ -5.43M$ -5.22M
Investing Cash Flow$ -17.50M$ -7.00K$ -2.32M$ 17.55M$ -4.29M
Financing Cash Flow$ 30.37M--$ 335.00K$ 7.52M
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

Corvus Pharmaceuticals Debt to Assets

Corvus Pharmaceuticals Cash Flow

Corvus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis